NCT05038761View on ClinicalTrials.gov

A Study to Learn How Well a Monitoring System Called Continuous Glucose Monitoring (CGM) Which Measures Glucose on an Ongoing Basis Works and How Safe it is in Chinese Patients in Usual Practice

CompletedOBSERVATIONAL
Enrollment

76

Participants

Timeline

Start Date

October 8, 2021

Primary Completion Date

January 29, 2022

Study Completion Date

March 21, 2022

Conditions
Continuous Glucose MonitoringDiabetes Mellitus
Interventions
DEVICE

CGM System

"Following the manner of observational study, no intervention will be used for the study.~Participants will wear the CGM on abdomen or lower area for no longer than 14 days."

PROCEDURE

Standard Venous Blood Glucose Test

Necessary venous blood glucose testing will be performed during the study as clinically required as comparator.

Trial Locations (2)

Unknown

Many locations, Multiple Locations

Many Locations, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT05038761 - A Study to Learn How Well a Monitoring System Called Continuous Glucose Monitoring (CGM) Which Measures Glucose on an Ongoing Basis Works and How Safe it is in Chinese Patients in Usual Practice | Biotech Hunter | Biotech Hunter